Quick Ratio in % of BioXcel Therapeutics, Inc. from Q4 2022 to Q3 2025

Taxonomy & unit
ratio: %
Description
The acid-test ratio, also called the quick ratio, is a metric used to see if a company is positioned to sell assets within 90 days to meet immediate expenses.
Summary
BioXcel Therapeutics, Inc. quarterly Quick Ratio history and change rate from Q4 2022 to Q3 2025.
  • BioXcel Therapeutics, Inc. Quick Ratio for the quarter ending 30 Sep 2025 was 1.92 %, a 75.2% decline year-over-year.
Quick Ratio, Quarterly (%)
Quick Ratio, YoY Quarterly Change (%)

BioXcel Therapeutics, Inc. Quarterly Quick Ratio (%)

Period Value YoY Chg Change % Date
Q3 2025 1.92 -5.82 -75.2% 30 Sep 2025
Q2 2025 3.14 -4.14 -56.9% 30 Jun 2025
Q1 2025 5.49 -0.81 -12.9% 31 Mar 2025
Q4 2024 6.87 +0.81 +13.4% 31 Dec 2024
Q3 2024 7.74 +1.94 +33.4% 30 Sep 2024
Q2 2024 7.28 +1.21 +19.9% 30 Jun 2024
Q1 2024 6.3 -0.12 -1.87% 31 Mar 2024
Q4 2023 6.06 +0.13 +2.19% 31 Dec 2023
Q3 2023 5.8 30 Sep 2023
Q2 2023 6.07 30 Jun 2023
Q1 2023 6.42 31 Mar 2023
Q4 2022 5.93 31 Dec 2022
* An asterisk sign (*) next to the value indicates that the value is likely invalid.